IndexIQ today announced plans to liquidate the following ETFs (the "Funds"):

The Funds will cease trading and no longer accept creation or redemption orders after market close on December 12, 2023. Proceeds of the liquidation are expected to be sent to shareholders on or about December 19, 2023.

About IndexIQ

IndexIQ is a New York Life Investments' platform of exchange-traded funds (ETFs) with over a decade of offering highly differentiated and innovative solutions to retail and institutional investors. With $9.7 billion in assets under management as of September 30, 2023, IndexIQ leverages the asset management capabilities of New York Life Investments' multi-boutique platform into its suite of offerings which include: fixed income, equities, alternatives, ESG components and specialty asset classes. For additional information on IndexIQ, visit https://www.newyorklifeinvestments.com/etf or follow us on Twitter or LinkedIn.

All investments are subject to risk and will fluctuate in value.

Consider the Funds' investment objectives, risks, charges and expenses carefully before investing. The prospectus and the statement of additional information include this and other relevant information about the Funds and are available by visiting IQetfs.com or calling (888) 474-7725. Read the prospectus carefully before investing.

IndexIQ^® is an indirect wholly owned subsidiary of New York Life Investment Management Holdings LLC and serves as the advisor to the IndexIQ ETFs. ALPS Distributors, Inc. (ALPS) is the principal underwriter of the ETFs, and NYLIFE Distributors LLC is a distributor of the ETFs. NYLIFE Distributors LLC is located at 30 Hudson Street, Jersey City, NJ 07302. ALPS Distributors, Inc. is not affiliated with NYLIFE Distributors LLC. "New York Life Investments" is both a service mark, and the common trade name, of the investment advisors affiliated with New York Life Insurance Company.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231019780214/en/

IndexIQ Announces Changes to ETF Lineup